ATAI News and Press, ATAI Life Sciences N.V. From 05/16/22

atai Life Sciences N.V. (ATAI) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Greg Weaver – Chief Financial Officer Florian Brand – Chief Executive Officer Srini Rao – Chief Scientific Officer Conference Call Participants Charles Duncan ...

German clinical-stage biopharmaceutical company Atai Life Sciences (NASDAQ:ATAI) is trading higher on Monday in reaction to the company’s 1Q 2022 results. The U.K.-based biotech COMPASS Pathways (CMPS), in which it holds an ownership stake, is also rising in solidarity. Atai&...

An earnings and business update video call today for Atai Life Sciences (NASDAQ-ATAI), a clinical-stage biopharmaceutical company that acquires, incubates and develops innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders, featured ...

ATAI Life Sciences press release (NASDAQ:ATAI): Q1 GAAP EPS of -$0.24 in-line. Cash, cash equivalents and short-term investments of $335M. “We made great progress in the first quarter on our mission to achieve clinically meaningful behavioral change in people living with mental health ...

– Strong execution across atai’s three strategic pillars: rapid acting pharmacological intervention, ongoing digital support and biomarker-driven precision mental health – Key milestones include first subject dosed in Phase 1 KUR-101, launch of drug discovery engi...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons , the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman says LSD and MDMA helped him alleviate symptoms rel...

Biotech stocks had enjoyed strong hype and trajectories in the recent past, especially during the pandemic years. This is beginning to unravel. ETFs covering this sector have a massive preponderance of U.S. stocks, historically the most overvalued market in the world. As growth st...

The financial players in the disruptive psychedelics industry have become part of a jigsaw hodge-podge of new and strategic investors each taking a risky shot in an industry that is slowly attracting more millionaires. They want to get their piece of the action. But with an ...

NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- In a release issued yesterday under the headline "atai Life Sciences to Announce First-Quarter 2022 Financial Results" by atai Life Sciences N.V. (Nasdaq: ATAI), please note the first and second paragraphs, which contained statements referencing th...

NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will announce its first-quarter 2022 financial results by posting them on the IR...